Clinical Manifestation of Calreticulin Gene Mutations in Essential Thrombocythemia without Janus Kinase 2 and MPL Mutations: A Chinese Cohort Clinical Study

BACKGROUND: Recently, calreticulin (CALR) gene mutations have been identified in patients with essential thrombocythemia (ET). A high-frequency of ET cases without Janus kinase 2 (JAK2) mutations contain CALR mutations and exhibit clinical characteristics different from those with mutant JAK2. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chao, Zhou, Xin, Zou, Zhi-Jian, Guo, Hong-Feng, Li, Jian-Yong, Qiao, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976563/
https://www.ncbi.nlm.nih.gov/pubmed/27453224
http://dx.doi.org/10.4103/0366-6999.186641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976563/
https://www.ncbi.nlm.nih.gov/pubmed/27453224
http://dx.doi.org/10.4103/0366-6999.186641

Ejemplares similares